Replidyne’s antibiotics fight drug-resistant bacteria

LOUISVILLE – As news of drug-resistant bacteria spread, Ken Collins and Nebojsa Janjic saw an opportunity. While the larger pharmaceutical companies were focusing on drugs for chronic conditions, Collins and Janjic founded Replidyne Inc. to develop new antibiotics designed to fight this tough bacteria.

?We were looking at an evergreen, unmet medical need as bugs will continue to develop resistance to existing antibiotics,? said Collins, president and chief executive officer of Replidyne, based in Louisville.

When they combined this market need with their core technology, they saw great possibilities. The company has one product planned to go to market in the…